$OSUR 3 SEC Filings

Filed On	Filing
14 May 2026	Form 3: Bertrand John D., Director No securities owned
02 Dec 2025	Form 3: Boyd Steven Kyle, Director No securities owned
10 Sep 2024	Form 3: Kenny John P., Director No securities owned
01 Aug 2023	Form 3: McMahon Robert W., Director No securities owned
15 Aug 2022	Form 3: McGrath Kenneth J, Chief Financial Officer No securities owned
06 Jun 2022	Form 3: Eglinton Manner Carrie, Director No securities owned
30 Nov 2021	Form 3: Gallagher Agnieszka, General Counsel & CCO No securities owned
23 Nov 2021	Form 3: Gagliano Nancy J, Director No securities owned
18 Nov 2021	Form 3: Whitaker Anne Clem, Director No securities owned
20 Sep 2021	Form 3: Gleason Scott, CFO Holds 20,439 shares of Common Stock
02 Jun 2020	Form 3: Marmora Lelio, Director No securities owned
14 May 2020	Form 3: Nibauer Lisa, EVP & BU Lead - Infectious No securities owned
08 Apr 2020	Form 3: Shulkin David, Director No securities owned
14 Aug 2019	Form 3: Datin James A, Director No securities owned
04 Jan 2019	Form 3: Weber Kathleen Gallagher, EVP & BU Lead - Molecular Holds 9,066 shares of Common Stock
02 Nov 2018	Form 3: Miller Michele Marie, VP, Finance and Controller Holds 1,573 shares of Common Stock
11 Jun 2018	Form 3: Cuca Roberto, CFO Holds 14,320 shares of Common stock
02 Feb 2018	Form 3: Sarin Aradhana, Director No securities owned
03 Aug 2017	Form 3: Smith Brian, SVP, Molecular Solutions Holds 26,540 shares of Common stock
22 Jun 2017	Form 3: Aspinall Mara G., Director No securities owned

Comments